Puma Biotechnology, Inc. 2020 Current Report 8-K
Puma Bio: Now Or Never. I Go With Never (NASDAQ:PBYI) | Seeking Alpha
Puma Bio: Sifting Through The Q4 Earnings Report (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Puma Bio Stock: Still Worthy After Earnings Surprise (NASDAQ:PBYI) | Seeking Alpha
Puma Bio (PBYI) Restricting Access to Breast Cancer Event at ASCO 2015 - TheStreet
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Bio: Recent Sell-Off Brings My Position Out Of Mothball (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Puma's BioEvolution Project Introduces A Shoe That Adapts To The Body – FashNerd
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Articles with Puma Biotechnology
Puma Biotechnology
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
